|
Teva Announces Positive Results From A Study Assessing A New Formulation Of Copaxone(R) |
|
08 Jun 2010
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced positive results from a study assessing a new lower-volume injection of Copaxone® (glatiramer acetate) containing the currently approved dose in half the injection volume. |
|
Read more...
|
|
|
|
|